Pulmonx (LUNG) Stock Statistics & Valuation Metrics

Pulmonx has a market cap or net worth of $121.98M. The enterprise value is $235.39M.

Pulmonx has 40,257,526 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pulmonx’s return on equity (ROE) is -0.66 and return on invested capital (ROIC) is -40.89%.

The current PE Ratio of Pulmonx is -4.71. Pulmonx’s PEG ratio is -0.30.

In the last 12 months, Pulmonx had revenue of 83.79M and earned -56.39M in profits. Earnings per share was -1.44.

In the last 12 months, operating cash flow was -32.96M and capital expenditures -1.30M, giving a free cash flow of -34.26M billion.

Pulmonx pays an annual dividend of ―, resulting in a dividend yield of ―

Pulmonx upcoming earnings date is Aug 5, 2025, TBA Not Confirmed.

Pulmonx as a current ratio of 5.58, with Debt / Equity ratio of 15.84%

In the past 12 months, Pulmonx has paid 500.00K in taxes.

Pulmonx EV to EBITDA ratio is -4.94, with an EV/FCF ratio of -7.61.

Pulmonx has $88.70M in cash and marketable securities with $56.95M in debt, giving a net cash position of -$31.75M billion.

Gross margin is 74.29%, with operating margin of -68.87%, and net profit margin of -67.30%.

The average price target for Pulmonx is $10.36, which is 11.43% higher than the current price. The consensus rating is Moderate Buy